A recent study published in JAMA reports that prophylactic antimicrobials increase the risk of antimicrobial resistance without decreasing the risk of recurrent urinary tract infections (UTIs ...
imaging and prophylaxis. New diagnostic criteria [3] Urinary tract infection (UTI) is the most common serious bacterial infection in childhood, and its management remains one of the most ...
The i on MSN4mon
‘Game changing’ chronic and recurrent UTI drug to be rolled out across NHS in weeks“The proposed new recommendations include considering methenamine hippurate, a urinary antiseptic drug, as an alternative to ...
Medscape Medical News, November 15, 2024 UTI Guideline Offers Clarity, Reveals Gaps The guideline covers a range of clinical topics, including prophylaxis and antimicrobial stewardship ...
Zydus Lifesciences has received USFDA approval to manufacture its generic version of Methenamine Hippurate tablets for ...
The tablets are indicated for prophylactic or suppressive treatment of frequently recurring urinary tract infections when ...
Zydus Lifesciences said that it has received final approval from the United States Food and Drug Administration (US FDA) to manufacture Methenamine Hippurate Tablets.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results